Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy.

Jiao, Yingwei; Liu, Qiang; Zhao, Hongbo; Hu, Xianzhen; Sun, Jinlong; Liu, Xiaohong

Jiao, Yingwei; Liu, Qiang; Zhao, Hongbo; Hu, Xianzhen; Sun, Jinlong; Liu, Xiaohong.

Afiliación

Jiao Y; Department of Proctology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China.
Liu Q; Department of Proctology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China.
Zhao H; Department of Proctology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China.
Hu X; Four Departments of General Surgery, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China.
Sun J; Department of Proctology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi 712000, China.
Liu X; Department of Traditional Chinese Medicine, Baoji Maternal and Child Health Care Hospital, Baoji, Shaanxi 721000, China.

Evid Based Complement Alternat Med ; 2021: 1858974, 2021.

Article en En | MEDLINE | ID: mdl-34589129

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Evid Based Complement Alternat Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google